Answer
Women of childbearing potential should use contraception while receiving ocrelizumab and for 4 months after their last dose.
Sources for this answer
- OCREVUS 300 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 20Document updated
Sources checked